<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="119495">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02107170</url>
  </required_header>
  <id_info>
    <org_study_id>VIAEV</org_study_id>
    <nct_id>NCT02107170</nct_id>
  </id_info>
  <brief_title>Effects of Anesthetics on Postoperative Cognitive Function of Patients Undergoing Endovascular Repair of Aortic Aneurysm and Endovascular Treatment of Arteriosclerosis Obliterans of Lower Extremities.</brief_title>
  <official_title>Comparison of Intravenous Anesthetics and Volatile Anesthetics on Postoperative Cognitive Dysfunction of Patients Undergoing Endovascular Repair of Aortic Aneurysm and Endovascular Treatment of Arteriosclerosis Obliterans of Lower Extremities.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tao Zhang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital, Sun Yat-Sen University</source>
  <oversight_info>
    <authority>National Health and Family Planning Commission: China.</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endovascular repair of aortic aneurysm and endovascular treatment of arteriosclerosis
      obliterans of lower extremities are two kinds of common surgeries in the investigators'
      hospital. The effects of anesthetic agents on postoperative outcome, especially cognitive
      function, are not clear. In this study investigators propose to measure postoperative
      cognitive function and other outcome of patients who are undergoing these two kinds of
      surgeries, and try to identify whether there is an association between different kinds of
      anesthetics and postoperative outcome. Investigators will also observe whether changes in
      plasma levels of VEGF, TGF-1, TNF-α, IL-1β, and IL-6, are associated with postoperative
      delirium or cognitive change.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Number of patients with postoperative cognitive dysfunction</measure>
    <time_frame>7 days after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with postoperative cognitive dysfunction</measure>
    <time_frame>3 months after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in plasma levels of VEGF, TGF-1, TNF-α, IL-1β, and IL-6 (a composite outcome measure)</measure>
    <time_frame>3 days after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Endovascular Repair of Aortic Aneurysm</condition>
  <condition>Endovascular Treatment of Arteriosclerosis Obliterans of Lower Extremities</condition>
  <arm_group>
    <arm_group_label>Sevoflurane &amp; remifentanil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>sevoflurane at 0.5 to 1.5 minimum alveolar concentrations plus remifentanil (0.1 - 0.5 µg/kg/min) during the surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>propofol &amp; remifentanil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>propofol (50 - 150 µg/kg/min) plus remifentanil (0.1 - 0.5 µg/kg/min) during the surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>sevoflurane-based general anesthesia</description>
    <arm_group_label>Sevoflurane &amp; remifentanil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>total intravenous anesthesia</description>
    <arm_group_label>propofol &amp; remifentanil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <arm_group_label>Sevoflurane &amp; remifentanil</arm_group_label>
    <arm_group_label>propofol &amp; remifentanil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-100 years of age

          -  Patients presenting for Endovascular repair of aortic aneurysm and endovascular
             treatment of arteriosclerosis obliterans of lower extremities

        Exclusion Criteria:

          -  Patients with pre-existing delirium

          -  Inablility to converse
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tao Zhang, Master of Medicine</last_name>
    <phone>13580482938</phone>
    <email>zhtao98@aliyun.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>First Affiliated Hospital, Sun Yat-Sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tao Zhang, Master of Medicine</last_name>
      <phone>13580482938</phone>
      <email>zhtao98@aliyun.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 4, 2014</lastchanged_date>
  <firstreceived_date>March 25, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital, Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>Tao Zhang</investigator_full_name>
    <investigator_title>Department of anesthesiology</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Arteriosclerosis</mesh_term>
    <mesh_term>Arteriosclerosis Obliterans</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Anesthetics, Intravenous</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
